On ECHEMI
Home > Drugs > Jiangsu Langou Pharmaceutical Co., Ltd.
Jiangsu Langou Pharmaceutical Co., Ltd.
  • Founded in:

    2013-06-21
  • Country:

    China China
  • Address:

    No. 1, Langou Road, Xuzhou Industrial Park, Jiangsu
  • Tax NO.:

    91320305071075704T
  • Registered Funds:

    100 million yuan
  • Email:

Related Drugs
Concentrated Sodium Chloride Injection
The main ingredients of this product and its chemical name: sodium chloride. Molecular formula: NaCl Molecular weight: 58.44
Name Description Content CAS NO. Registered Holders
Sodium chloride

Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.

More

Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.

7647-14-5 43
Kanamycin Sulfate Injection
The main ingredient of this product is kanamycin sulfate, which is a multi-component antibiotic containing three components A, B and C, with A being the main component.
Name Description Content CAS NO. Registered Holders
Kanamycin sulfate

It has good antibacterial effect on most Enterobacteriaceae such as Escherichia coli, Klebsiella, Enterobacter, Proteus, Shigella, Salmonella, Citrobacter, Providencia, Yersinia, etc.; influenza bacillus, Brucella, meningococcus, gonococcus, etc. are mostly sensitive. It has a certain effect on Staphylococcus (methicillin-sensitive strains) and Mycobacterium tuberculosis, but is ineffective against Pseudomonas aeruginosa. Most other Gram-positive bacteria such as hemolytic streptococci, Streptococcus pneumoniae, Enterococcus and anaerobic bacteria are resistant. It mainly binds to the 30S subunit of the bacterial ribosome and inhibits bacterial protein synthesis. In recent years, the number of resistant strains has increased significantly, because some bacteria produce aminoglycoside inactivating enzymes, which make them lose their antibacterial activity. Kanamycin has complete cross-resistance with streptomycin and neomycin, and may have partial cross-resistance with other aminoglycosides.

More

It has good antibacterial effect on most Enterobacteriaceae such as Escherichia coli, Klebsiella, Enterobacter, Proteus, Shigella, Salmonella, Citrobacter, Providencia, Yersinia, etc.; influenza bacillus, Brucella, meningococcus, gonococcus, etc. are mostly sensitive. It has a certain effect on Staphylococcus (methicillin-sensitive strains) and Mycobacterium tuberculosis, but is ineffective against Pseudomonas aeruginosa. Most other Gram-positive bacteria such as hemolytic streptococci, Streptococcus pneumoniae, Enterococcus and anaerobic bacteria are resistant. It mainly binds to the 30S subunit of the bacterial ribosome and inhibits bacterial protein synthesis. In recent years, the number of resistant strains has increased significantly, because some bacteria produce aminoglycoside inactivating enzymes, which make them lose their antibacterial activity. Kanamycin has complete cross-resistance with streptomycin and neomycin, and may have partial cross-resistance with other aminoglycosides.

25389-94-0 9
Xanthinol Nicotinate Injection
Each ampoule contains 300 mg of XanthinolNicotinate
Name Description Content CAS NO. Registered Holders
Xanthinol nicotinate

Reduce peripheral vascular resistance, increase cardiac output, reduce venous pressure, activate fibrinolysis, reduce fibrinogen levels, prevent platelet aggregation, promote the synthesis of pyrimidine nucleosides (NAD and NADP), increase the concentration of adenine nucleosides (AMP, ADP and ATP), hinder lipolysis, and reduce elevated cholesterol and triglyceride levels

More

Reduce peripheral vascular resistance, increase cardiac output, reduce venous pressure, activate fibrinolysis, reduce fibrinogen levels, prevent platelet aggregation, promote the synthesis of pyrimidine nucleosides (NAD and NADP), increase the concentration of adenine nucleosides (AMP, ADP and ATP), hinder lipolysis, and reduce elevated cholesterol and triglyceride levels

300mg 437-74-1 9
Betahistine Hydrochloride Injection
The main ingredient of this product is betahistine hydrochloride, and its chemical name is: N-methyl-2-pyridineethylamine dihydrochloride.
Name Description Content CAS NO. Registered Holders
Betastatin hydrochloride

This product is a diamine oxidase inhibitor, which has a significant dilating effect on cerebrovascular and cardiovascular vessels, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstriction effect of catecholamines and reduce arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

More

This product is a diamine oxidase inhibitor, which has a significant dilating effect on cerebrovascular and cardiovascular vessels, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstriction effect of catecholamines and reduce arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

0
Sodium Glucuronate Injection
The main ingredient is sodium glucuronate.
Name Description Content CAS NO. Registered Holders
D-Glucuronic acid sodium salt

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

More

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

14984-34-0 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.